Intech Investment Management LLC Akebia Therapeutics, Inc. Transaction History
Intech Investment Management LLC
- $10.2 Billion
- Q2 2025
A detailed history of Intech Investment Management LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 142,928 shares of AKBA stock, worth $315,870. This represents 0.01% of its overall portfolio holdings.
Number of Shares
142,928
Previous 127,359
12.22%
Holding current value
$315,870
Previous $244,000
113.11%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AKBA
# of Institutions
174Shares Held
106MCall Options Held
134KPut Options Held
262K-
Vanguard Group Inc Valley Forge, PA14.6MShares$32.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$25.7 Million0.0% of portfolio
-
State Street Corp Boston, MA8MShares$17.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.07MShares$13.4 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$12.7 Million20.26% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $406M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...